Harmon Seth sold VRDN
March 3, 2026 · Form 4 insider transaction
Harmon Seth sold 2,091 shares of Viridian Therapeutics, Inc. at $29.32 per share, a transaction worth $61.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,091
Price
$29.32
Total value
$61.3K
InsiderHarmon Seth
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 3, 2026
Filing dateMarch 4, 2026
Shares owned after7,790
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 903 shares acquired on March 17, 2025 under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan and 1,000 shares acquired on September 17, 2025 under Viridian Therapeutics, Inc.'s 2025 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).